NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Ruth O Regan
AD Scientific Index 2024
Others
University of Wisconsin Madison - Madison / United States
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Ruth O Regan's MOST POPULAR ARTICLES
1-)
Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncologyWJ Gradishar, BO Anderson, J Abraham, R Aft, D Agnese, KH Allison, ...Journal of the National Comprehensive Cancer Network 18 (4), 452-478, 20207082020
2-)
Emerging use of nanoparticles in diagnosis and treatment of breast cancerMV Yezhelyev, X Gao, Y Xing, A Al-Hajj, S Nie, RM O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'ReganThe lancet oncology 7 (8), 657-667, 20067052006
3-)
The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapyZ Mitri, T Constantine, R O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'ReganChemotherapy research and practice 2012, 20126592012
4-)
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistryY Xing, Q Chaudry, C Shen, KY Kong, HE Zhau, LW Chung, JA Petros, ...Nature protocols 2 (5), 1152-1165, 20076622007
5-)
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trialF André, R O\'Regan, M Ozguroglu, M Toi, B Xu, G Jerusalem, N Masuda, ...The lancet oncology 15 (6), 580-591, 20145762014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept